> United Drug has bought pharma risk-management contractor Drug Safety Alliance for $21 million and market-access firm Synopia for $12 million. News
> Numoda has signed up to conduct Phase I trials for Proteonomix's UMK-121 for end-stage liver disease. More
> Harlan Laboratories is expanding its agrochemicals and global pathology units, appointing new general managers for each. Story
> Icon ($ICLR) is expanding some of its labs in the U.S. and U.K., adding space for dedicated immunoassay development. Article
> WuXi PharmaTech ($WX) has entered a drug discovery pact with Open Monoclonal Technology, looking to discover antibodies using OMT's rat models. Report
> CMIC got qualification for three new development suites in New Jersey, a development the company says will help speed up drug development. Item